1
|
Bloska J, Crabtree S, Wollersberger N, Mitchell O, Coles J, Halsey C, Parry G, Stewart R, Thacker S, Thacker M, Claydon-Mueller L, Winnard Y, McMahon K, Petrowitz C, Smrokowska-Reichmann A, van Doorn B, Baker FA, Blauth L, Bukowska AA, Stensæth K, Tamplin J, Wosch T, Odell-Miller H. Experiences of participant and public involvement in an international randomized controlled trial for people living with dementia and their informal caregivers. RESEARCH INVOLVEMENT AND ENGAGEMENT 2024; 10:43. [PMID: 38698480 PMCID: PMC11064380 DOI: 10.1186/s40900-024-00574-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/04/2023] [Accepted: 04/18/2024] [Indexed: 05/05/2024]
Abstract
BACKGROUND This study was initiated and co-designed by a Participant and Public Involvement (PPI) group attached to HOMESIDE, a randomized controlled trial that investigated music and reading interventions for people living with dementia and their family caregivers across five countries: Australia, Germany, Norway, Poland, and the UK. The aim was to capture experiences of PPI across the five countries, explore the benefits and challenges of PPI in dementia research, and identify contributions made to the study. METHODS We surveyed PPI members and academic researchers who collaborated on the HOMESIDE study. The survey was co-designed through consultation with PPI members and academics, alongside a small scoping literature review. Survey questions covered four topics: (1) expectations for PPI, (2) perceived contributions of PPI to the research study, (3) benefits and challenges of PPI, and (4) recommendations for future PPI in dementia research. RESULTS There were 23 responses, representing 50% of the PPI members (n = 16) and 29% of academics (n = 7). PPI was found to be beneficial to the research and individuals involved. Contributions to the research included supporting recruitment and publicity, advising on the design of participant-facing materials, guiding the design and delivery of the interventions, and identifying cultural differences affecting research delivery. PPI members benefited from building connections, sharing experiences and receiving support, learning about dementia and research, and gaining new unexpected experiences. Academics learned about the realities of living with dementia, which they felt informed and grounded their work. Several challenges were identified, including the need for clear expectations and objectives, inconsistency of PPI members across research stages, limitations of meeting online versus in-person, scheduling difficulties, and language barriers. CONCLUSIONS This study identifies important considerations for implementing PPI within dementia studies and international healthcare research more broadly. Our findings guided the development of five recommendations: (1) involve PPI members as early as possible and throughout the research process; (2) create a space for constructive criticism and feedback; (3) have clear tasks, roles, and expectations for PPI members; (4) involve PPI members with a diverse range of experiences and backgrounds; and (5) embed infrastructure and planning to support PPI.
Collapse
Grants
- the National Health and Medical Research Council, Australia (APP1169867); The Research Council of Norway (project no. 298995); Federal Ministry of Education and Research, Germany (01ED1901); The National Centre for Research and Development, Poland (JPND/04/2019); and Alzheimer's Society, UK (grant no. 462). EU Joint Programme - Neurodegenerative Disease Research
- the National Health and Medical Research Council, Australia (APP1169867); The Research Council of Norway (project no. 298995); Federal Ministry of Education and Research, Germany (01ED1901); The National Centre for Research and Development, Poland (JPND/04/2019); and Alzheimer's Society, UK (grant no. 462). EU Joint Programme - Neurodegenerative Disease Research
- the National Health and Medical Research Council, Australia (APP1169867); The Research Council of Norway (project no. 298995); Federal Ministry of Education and Research, Germany (01ED1901); The National Centre for Research and Development, Poland (JPND/04/2019); and Alzheimer's Society, UK (grant no. 462). EU Joint Programme - Neurodegenerative Disease Research
- the National Health and Medical Research Council, Australia (APP1169867); The Research Council of Norway (project no. 298995); Federal Ministry of Education and Research, Germany (01ED1901); The National Centre for Research and Development, Poland (JPND/04/2019); and Alzheimer's Society, UK (grant no. 462). EU Joint Programme - Neurodegenerative Disease Research
- the National Health and Medical Research Council, Australia (APP1169867); The Research Council of Norway (project no. 298995); Federal Ministry of Education and Research, Germany (01ED1901); The National Centre for Research and Development, Poland (JPND/04/2019); and Alzheimer's Society, UK (grant no. 462). EU Joint Programme - Neurodegenerative Disease Research
- the National Health and Medical Research Council, Australia (APP1169867); The Research Council of Norway (project no. 298995); Federal Ministry of Education and Research, Germany (01ED1901); The National Centre for Research and Development, Poland (JPND/04/2019); and Alzheimer's Society, UK (grant no. 462). EU Joint Programme - Neurodegenerative Disease Research
- the National Health and Medical Research Council, Australia (APP1169867); The Research Council of Norway (project no. 298995); Federal Ministry of Education and Research, Germany (01ED1901); The National Centre for Research and Development, Poland (JPND/04/2019); and Alzheimer's Society, UK (grant no. 462). EU Joint Programme - Neurodegenerative Disease Research
- the National Health and Medical Research Council, Australia (APP1169867); The Research Council of Norway (project no. 298995); Federal Ministry of Education and Research, Germany (01ED1901); The National Centre for Research and Development, Poland (JPND/04/2019); and Alzheimer's Society, UK (grant no. 462). EU Joint Programme - Neurodegenerative Disease Research
- the National Health and Medical Research Council, Australia (APP1169867); The Research Council of Norway (project no. 298995); Federal Ministry of Education and Research, Germany (01ED1901); The National Centre for Research and Development, Poland (JPND/04/2019); and Alzheimer's Society, UK (grant no. 462). EU Joint Programme - Neurodegenerative Disease Research
- the National Health and Medical Research Council, Australia (APP1169867); The Research Council of Norway (project no. 298995); Federal Ministry of Education and Research, Germany (01ED1901); The National Centre for Research and Development, Poland (JPND/04/2019); and Alzheimer's Society, UK (grant no. 462). EU Joint Programme - Neurodegenerative Disease Research
- EU Joint Programme – Neurodegenerative Disease Research
- Anglia Ruskin University
Collapse
Affiliation(s)
- Jodie Bloska
- Cambridge Institute for Music Therapy Research, Anglia Ruskin University, Cambridge, UK.
| | - Sarah Crabtree
- Cambridge Institute for Music Therapy Research, Anglia Ruskin University, Cambridge, UK
| | - Nina Wollersberger
- Cambridge Institute for Music Therapy Research, Anglia Ruskin University, Cambridge, UK
| | - Oti Mitchell
- Public Contributor, Cambridge Institute for Music Therapy Research, Anglia Ruskin University, Cambridge, UK
| | - Jenny Coles
- Public Contributor, Cambridge Institute for Music Therapy Research, Anglia Ruskin University, Cambridge, UK
| | - Caroline Halsey
- Public Contributor, Cambridge Institute for Music Therapy Research, Anglia Ruskin University, Cambridge, UK
| | - Geraldine Parry
- Public Contributor, Cambridge Institute for Music Therapy Research, Anglia Ruskin University, Cambridge, UK
| | - Robert Stewart
- Public Contributor, Cambridge Institute for Music Therapy Research, Anglia Ruskin University, Cambridge, UK
| | - Susan Thacker
- Public Contributor, Cambridge Institute for Music Therapy Research, Anglia Ruskin University, Cambridge, UK
| | - Mark Thacker
- Public Contributor, Cambridge Institute for Music Therapy Research, Anglia Ruskin University, Cambridge, UK
| | - Leica Claydon-Mueller
- School of Allied Health and Social Care, Faculty of Health, Medicine and Social Care, Anglia Ruskin University, Cambridge, UK
| | - Yvette Winnard
- School of Allied Health and Social Care, Faculty of Health, Medicine and Social Care, Anglia Ruskin University, Cambridge, UK
| | - Kate McMahon
- Faculty of Fine Arts and Music, The University of Melbourne, Melbourne, Australia
| | - Carina Petrowitz
- Institute for Applied Social Sciences, Technical University of Applied Sciences Würzburg-Schweinfurt, Würzburg, Germany
| | | | - Beatrix van Doorn
- Singing in Elderly Care, Singing Norway, Oslo, Norway
- Public Contributor, Centre for Research in Music and Health, Norwegian Academy of Music, Oslo, Norway
| | - Felicity A Baker
- Faculty of Fine Arts and Music, The University of Melbourne, Melbourne, Australia
- Centre for Research in Music and Health, Norwegian Academy of Music, Oslo, Norway
| | - Laura Blauth
- Institute of Applied Sciences, University of Physical Education in Kraków, Kraków, Poland
| | - Anna A Bukowska
- Institute of Applied Sciences, University of Physical Education in Kraków, Kraków, Poland
| | - Karette Stensæth
- Centre for Research in Music and Health, Norwegian Academy of Music, Oslo, Norway
| | - Jeanette Tamplin
- Faculty of Fine Arts and Music, The University of Melbourne, Melbourne, Australia
| | - Thomas Wosch
- Institute for Applied Social Sciences, Technical University of Applied Sciences Würzburg-Schweinfurt, Würzburg, Germany
| | - Helen Odell-Miller
- Cambridge Institute for Music Therapy Research, Anglia Ruskin University, Cambridge, UK
| |
Collapse
|
2
|
Aguzzoli Peres F, Haas AN, Martha AD, Chan M, Steele M, Ferretti MT, Ngcobo NN, Ilinca S, Domínguez‐Vivero C, Leroi I, Sajnani N, Zimmer ER, Kornhuber A, Kalache A, Holtzhausen B, Tristão‐Pereira C, Dupont C, Cohen D, de Jong D, Facal D, O'Sullivan D, Mateus E, Roso E, Estrop E, Gamba G, San Martin Elexpe G, Ulises Diaz Hernández H, Quaid H, Govia I, Barbosa J, García del Moral J, Miller J, García García JA, Quaid K, Navarro L, García LZ, Waters L, Molete L, Godoy ME, Sigauke M, de Ataide Schulte MW, Estrop P, San Martin Elexpe Cardoso P, Perez R, Patterson R, Chakrabarti R, Wong R, Marsillas S, Lowe S, Rego TS, Farombi T, Montgomery T, in ‘t Veen T, Yanni V, Weidner W, Ibanez A. Walking the talk for dementia: A unique immersive, embodied, and multi-experiential initiative. Alzheimers Dement 2024; 20:2309-2322. [PMID: 38275208 PMCID: PMC10984440 DOI: 10.1002/alz.13644] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2023] [Revised: 11/26/2023] [Accepted: 11/27/2023] [Indexed: 01/27/2024]
Abstract
Coping with dementia requires an integrated approach encompassing personal, health, research, and community domains. Here we describe "Walking the Talk for Dementia," an immersive initiative aimed at empowering people with dementia, enhancing dementia understanding, and inspiring collaborations. This initiative involved 300 participants from 25 nationalities, including people with dementia, care partners, clinicians, policymakers, researchers, and advocates for a 4-day, 40 km walk through the Camino de Santiago de Compostela, Spain. A 2-day symposium after the journey provided novel transdisciplinary and horizontal structures, deconstructing traditional hierarchies. The innovation of this initiative lies in its ability to merge a physical experience with knowledge exchange for diversifying individuals' understanding of dementia. It showcases the transformative potential of an immersive, embodied, and multi-experiential approach to address the complexities of dementia collaboratively. The initiative offers a scalable model to enhance understanding, decrease stigma, and promote more comprehensive and empathetic dementia care and research.
Collapse
|
3
|
Clarke E, Anderson-Saria G, Kisoli A, Urasa S, Moloney S, Safic S, Rogathi J, Walker R, Robinson L, Paddick SM. Patient priority setting in HIV ageing research: exploring the feasibility of community engagement and involvement in Tanzania. RESEARCH INVOLVEMENT AND ENGAGEMENT 2023; 9:3. [PMID: 36805028 PMCID: PMC9938604 DOI: 10.1186/s40900-022-00409-y] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/01/2022] [Accepted: 12/23/2022] [Indexed: 06/18/2023]
Abstract
OBJECTIVE The chronic complications of ageing with HIV are not well studied in sub-Saharan Africa (SSA) where general healthcare resources are limited. We aimed to collaborate with individuals living with HIV aged ≥ 50 years, and community elders (aged ≥ 60 years) living with non-communicable diseases in the Kilimanjaro region of Tanzania in a health research priority-setting exercise. METHODS We conducted structured workshops based on broad questions to aid discussion and group-based patient priority setting, alongside discussion of the feasibility of future community research engagement. Participant priorities were tallied and ranked to arrive at core priorities from consensus discussion. RESULTS Thirty older people living with HIV and 30 community elders attended separate priority setting workshops. Both groups reported motivation to participate in, conduct, and oversee future studies. In this resource-limited setting, basic needs such as healthcare access were prioritised much higher than specific HIV-complications or chronic disease. Stigma and social isolation were highly prioritised in those living with HIV. CONCLUSIONS Community engagement and involvement in HIV and ageing research appears feasible in Tanzania. Ageing and non-communicable disease research should consider the wider context, and lack of basic needs in low-income settings. A greater impact may be achieved with community involvement.
Collapse
Affiliation(s)
- Ellisiv Clarke
- Newcastle University, Campus for Ageing and Vitality, Westgate Road, Newcastle Upon Tyne, NE4 6BE, UK
| | | | - Aloyce Kisoli
- Anderson Memorial Rehabilitation and Care Organisation (AMRCO), Moshi, Tanzania
| | - Sarah Urasa
- Kilimanjaro Christian Medical University College, Moshi, Tanzania
| | - Susan Moloney
- Newcastle University, Campus for Ageing and Vitality, Westgate Road, Newcastle Upon Tyne, NE4 6BE, UK
| | | | - Jane Rogathi
- Kilimanjaro Christian Medical University College, Moshi, Tanzania
| | - Richard Walker
- Newcastle University, Campus for Ageing and Vitality, Westgate Road, Newcastle Upon Tyne, NE4 6BE, UK
- Northumbria Healthcare NHS Foundation Trust, North Tyneside General Hospital, North Shields, UK
| | - Louise Robinson
- Newcastle University, Campus for Ageing and Vitality, Westgate Road, Newcastle Upon Tyne, NE4 6BE, UK
| | - Stella-Maria Paddick
- Newcastle University, Campus for Ageing and Vitality, Westgate Road, Newcastle Upon Tyne, NE4 6BE, UK.
- Gateshead Health NHS Foundation Trust, Gateshead, UK.
| |
Collapse
|
4
|
Leroi I, Karanja W, Adrion ER, Alladi S, Custodio N, Goswami SP, Guerchet M, Gubner J, Ibanez A, Ilinica S, Jafri H, Lawlor B, Mohamed AA, Ogunniyi A, Robertson I, Robinson L, Spector A, Varghese M, Weidner W, Caramelli P. Equity and balance in applied dementia research: A charter of conduct and checklist for global collaborations. Int J Geriatr Psychiatry 2022; 37. [PMID: 35703570 DOI: 10.1002/gps.5762] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/11/2022] [Accepted: 05/04/2022] [Indexed: 11/09/2022]
Affiliation(s)
- Iracema Leroi
- Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland
| | - Wambui Karanja
- Atlantic Fellow for Equity in Brain Health, Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland
| | - Emily R Adrion
- Atlantic Fellow for Equity in Brain Health, Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.,School of Social and Political Science at the University of Edinburgh, Edinburgh, Scotland
| | - Suvarna Alladi
- Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India
| | - Nilton Custodio
- Servicio de Neurología, Instituto Peruano de Neurociencias, Lima, Perú
| | - S P Goswami
- All India Institute of Speech & Hearing, Mysuru, India
| | - Maëlenn Guerchet
- Atlantic Fellow for Equity in Brain Health, Global Brain Health Institute, University of California San Francisco, San Francisco, California, USA
| | - Jennie Gubner
- Atlantic Fellow for Equity in Brain Health, Global Brain Health Institute, University of California San Francisco, San Francisco, California, USA
| | - Agustin Ibanez
- Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.,Atlantic Fellow for Equity in Brain Health, Global Brain Health Institute, University of California San Francisco, San Francisco, California, USA.,Latin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago de Chile, Santiago, Chile.,Cognitive Neuroscience Center (CNC), Universidad de San Andrés, Atlantic Fellow for Equity in Brain Health, Global Brain Health Institute, Buenos Aires, Argentina
| | - Stefania Ilinica
- Atlantic Fellow for Equity in Brain Health, Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland
| | - Hussain Jafri
- Fatima Jinnah Medical University Lahore, Lahore, Pakistan
| | - Brian Lawlor
- Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland
| | - Aya Ashour Mohamed
- Atlantic Fellow for Equity in Brain Health, Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.,Department of Neurology, Ain Shams University, Cairo, Egypt
| | - Adesola Ogunniyi
- Department of Neurology, University College Hospital, Ibadan, Nigeria
| | - Ian Robertson
- Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland
| | - Louise Robinson
- Population Heath Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK
| | - Aimee Spector
- Department of Clinical, Educational and Health Psychology, University College London, London, UK
| | - Mathew Varghese
- Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India
| | | | - Paulo Caramelli
- Behavioral and Cognitive Neurology Research Group, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
| | | |
Collapse
|
5
|
Cluley V, Ziemann A, Feeley C, Olander EK, Shamah S, Stavropoulou C. Mapping the role of patient and public involvement during the different stages of healthcare innovation: A scoping review. Health Expect 2022; 25:840-855. [PMID: 35174585 DOI: 10.1111/hex.13437] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2021] [Revised: 01/05/2022] [Accepted: 01/06/2022] [Indexed: 11/30/2022] Open
Abstract
BACKGROUND Patient and public involvement (PPI) has become increasingly important in the development, delivery and improvement of healthcare. PPI is used in healthcare innovation; yet, how it is used has been under-reported. The aim of this scoping review is to identify and map the current available empirical evidence on the role of PPI during different stages of healthcare innovation. METHODS The scoping review was conducted in accordance with PRISMAScR and included any study published in a peer-reviewed journal between 2004 and 2021 that reported on PPI in healthcare innovation within any healthcare setting or context in any country. The following databases were searched: Medline, EMBASE, CINAHL, PsycInfo, HMIC and Google Scholar. We included any study type, including quantitative, qualitative and mixed-method studies. We excluded theoretical frameworks, conceptual, scientific or grey literature as well as discussion and opinion papers. RESULTS Of the 87 included studies, 81 (93%) focused on or were conducted by authors in developed countries. A wide range of conditions were considered, with more studies focusing on mental health (n = 18, 21%) and cancer care (n = 8, 9%). The vast majority of the studies focused on process and service innovations (n = 62, 71%). Seven studies focused on technological and clinical innovations (8%), while 12 looked at both technological and service innovations (14%). Only five studies examined systems innovation (5%) and one study looked across all types of innovations (1%). PPI is more common in the earlier stages of innovation, particularly problem identification and invention, in comparison to adoption and diffusion. CONCLUSION Healthcare innovation tends to be a lengthy process. Yet, our study highlights that PPI is more common across earlier stages of innovation and focuses mostly on service innovation. Stronger PPI in later stages could support the adoption and diffusion of innovation. PATIENT OR PUBLIC CONTRIBUTION One of the coauthors of the paper (S. S.) is a service user with extensive experience in PPI research. S. S. supported the analysis and writing up of the paper.
Collapse
Affiliation(s)
- Victoria Cluley
- Department of Cardiovascular Sciences, University of Leicester, Leicester, UK
| | - Alexandra Ziemann
- Centre for Healthcare Innovation Research, City, University of London, London, UK
| | - Claire Feeley
- School of Community Health and Midwifery, University of Central Lancashire, Preston, UK
| | - Ellinor K Olander
- Centre for Maternal and Child Health Research, School of Health Sciences, City, University of London, London, UK
| | - Shani Shamah
- Service-User, Research (Public Patient Involvement) Consultant, Independent, London, UK
| | - Charitini Stavropoulou
- Centre for Healthcare Innovation Research, City, University of London, London, UK.,School of Health Sciences, City, University of London, London, UK
| |
Collapse
|
6
|
Sheikh S, Tofique S, Zehra N, Amjad R, Rasheed M, Usman M, Lal S, Hooper E, Miah J, Husain N, Jafri H, Chaudhry N, Leroi I. SENSE-Cog Asia: A Feasibility Study of a Hearing Intervention to Improve Outcomes in People With Dementia. Front Neurol 2021; 12:654143. [PMID: 34194381 PMCID: PMC8236518 DOI: 10.3389/fneur.2021.654143] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2021] [Accepted: 05/07/2021] [Indexed: 11/19/2022] Open
Abstract
Background: There are few evidence-based non-pharmacological interventions adapted for people with dementia (PwD) in lower- and middle-income countries (LMIC). Thus, there is value in culturally adapting existing interventions from other settings. One such intervention for PwD involves hearing rehabilitation, which may improve dementia-related outcomes. Objective: To culturally adapt and evaluate the feasibility and acceptability of a multi-faceted hearing support intervention to enhance quality of life in PwD for a LMIC setting, Pakistan. Design: This was a study in three phases: (1) training and capacity building to deliver the study, including Patient and Public Involvement (PPI); (2) cultural adaptation of the intervention; and (3) delivery of a single-group feasibility study with a pre-test post-test design. Setting: Home-based intervention, in two cities of Pakistan. Participants: Adults aged ≥ 60 with mild-moderate dementia and uncorrected or partially corrected hearing impairment, and their study partners (n = 14). Intervention: An adapted hearing support intervention (HSI) comprising a full assessment of hearing function, fitting of hearing aids, and home-based support from a “hearing support practitioner.” Outcomes: Ratings of the feasibility of the study procedures, and acceptability/tolerability of the adapted intervention were ascertained through questionnaires, participant diaries, therapist logbooks and semi-structured interviews. A signal of effectiveness of the intervention was also explored using a battery of dementia-related outcome measures. Results: Following cultural adaptation and capacity building for study conduct and delivery, we successfully implemented all intervention components in most participants, which were well-received and enacted by participant dyads. Acceptability (i.e., understanding, motivation, sense of achievement) and tolerability (i.e., effort, fatigue) ratings and safety of the intervention were within a priori target ranges. Recruitment and retention targets required improvement, due to the COVID-19 pandemic outbreak, as well as the lack of a clear clinical diagnostic pathway for dementia in both sites. Areas for future modification were clearly identified, including: the assessment/delivery logistics circuit; procedures for arranging visits; communication among referring clinicians and the study team. Conclusion: This is the first study in a LMIC of sensory enhancement to improve dementia outcomes. Positive feasibility, acceptability and tolerability findings suggest that a full-scale effectiveness trial, with certain modifications is warranted.
Collapse
Affiliation(s)
- Saima Sheikh
- Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, United Kingdom
| | - Sehrish Tofique
- Department of Psychiatry, Pakistan Institute of Living and Learning, Karachi, Pakistan
| | - Nosheen Zehra
- Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, United Kingdom
| | - Rabia Amjad
- Department of Psychiatry, Pakistan Institute of Living and Learning, Karachi, Pakistan
| | - Maham Rasheed
- Department of Psychiatry, Pakistan Institute of Living and Learning, Karachi, Pakistan
| | - Maria Usman
- Department of Psychiatry, Pakistan Institute of Living and Learning, Karachi, Pakistan
| | - Shanker Lal
- Department of Psychiatry, Pakistan Institute of Living and Learning, Karachi, Pakistan
| | - Emma Hooper
- Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, United Kingdom.,Department of Health, Institute of Health, University of Cumbria, Lancaster, United Kingdom
| | - Jahanara Miah
- Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, United Kingdom
| | - Nusrat Husain
- Division of Global Mental Health, University of Manchester, Manchester, United Kingdom
| | - Hussain Jafri
- Department of Health, Alzheimer Pakistan, Lahore, Pakistan.,Department of Health, Fatima Jinnah Medical University, Lahore, Pakistan
| | - Nasim Chaudhry
- Department of Psychiatry, Pakistan Institute of Living and Learning, Karachi, Pakistan
| | - Iracema Leroi
- Department of Psychiatry, Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland
| |
Collapse
|